Welcome to Multibagg AI
Log in to access personalized features
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Portfolio
Alerts
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
1.18 | 87 Cr | 11.60 | 0.40 | 0.00 | 3.54 | 5.51 | 2.59 | ||
33.99 | 84 Cr | 376.44 | 6.17 | 0.00 | 1.64 | 5.53 | 1.58 | ||
43.18 | 83 Cr | 8.41 | 0.77 | 0.00 | 9.16 | 12.19 | 4.53 | ||
4.30 | 83 Cr | 24.88 | 1.63 | 0.00 | 6.59 | 10.22 | 3.00 | ||
18.93 | 82 Cr | — | 6.17 | 0.00 | -66.58 | -20.93 | -9.55 | ||
16.10 | 80 Cr | 21.16 | 1.41 | 0.00 | 6.68 | 6.64 | 6.27 | ||
31.99 | 80 Cr | 12.69 | 0.47 | 0.78 | 3.74 | 3.45 | 1.73 | ||
| Median: 7 Co. | — | 18.93 | 83 Cr | 16.93 | 1.41 | 0.00 | 3.74 | 5.53 | 2.59 |
Fervent Synergies Ltd is engaged in the trading and distribution of pharmaceutical and chemical products, focusing on APIs, solvents, intermediates, and bulk drugs.
Originally incorporated as Fervent Pharma Synergies Ltd in 2009, the company underwent a name change in 2012 after mergers with Midas Pharmasec Ltd and Yew Investment Pvt Ltd.
The company expanded its scope by merging with Midas Pharmasec Ltd, enhancing its pharmaceutical business operations and gaining synergies.
Fervent Synergies Ltd's shares are publicly traded on the Bombay Stock Exchange since January 12, 2012, providing investor access and funding opportunities.
Their primary business operations include import-export activities, leveraging global connections to distribute a wide array of chemical products.
Commercial Services & Supplies
Trading & Distributors
80 Cr
Low Risk
22.1
21.3
0.2
1.4
27.43
13.05
Sales CAGR
Profit CAGR
ROE
ROCE
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
Fervent Synergies Ltd (FERVENTSYN) is currently trading at 15.88 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Fervent Synergies Ltd is engaged in the trading and distribution of pharmaceutical and chemical products, focusing on APIs, solvents, intermediates, and bulk drugs. Originally incorporated as Fervent Pharma Synergies Ltd in 2009, the company underwent a name change in 2012 after mergers with Midas Pharmasec Ltd and Yew Investment Pvt Ltd. The company expanded its scope by merging with Midas Pharmasec Ltd, enhancing its pharmaceutical business operations and gaining synergies. Fervent Synergies Ltd's shares are publicly traded on the Bombay Stock Exchange since January 12, 2012, providing investor access and funding opportunities. Their primary business operations include import-export activities, leveraging global connections to distribute a wide array of chemical products.
Over the past 52 weeks, Fervent Synergies Ltd has traded between a low of ₹13.05 and a high of ₹27.43. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Fervent Synergies Ltd has a market capitalization of approximately 80.40. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Fervent Synergies Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 22.09 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 80.40 Cr, Fervent Synergies Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Fervent Synergies Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Fervent Synergies Ltd is 22.09. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Financial Results
Fervent Synergies approved unaudited results for quarter ended 30-06-2026 with auditor review; 17th AGM on 2026-08-27 at 11:00 AM (VC); book closure 2026-08-21 to 2026-08-27; cut-off date 2026-08-20.
Financial Results
Fervent Synergies' board (23-Jul-2026) approved unaudited Q1 results for quarter ended 30-Jun-2026 with auditor review. 17th AGM fixed for 27-Aug-2026 at 11:00 AM (VC/OVAM); register closed 21-27 Aug; cut-off 20-Aug-2026.
Financial Results
Fervent Synergies Ltd board approved unaudited results for quarter ended 30-06-2026 with auditors' review; 17th AGM set for 27-08-2026 (VC/OVAM); books close 21-08-2026 to 27-08-2026.
Financial Results
Fervent Synergies Ltd: Board approved unaudited results for quarter ended 30-06-2026 with auditors' review. 17th AGM on 2026-08-27 at 11:00 AM via VC/OVAM; record/closure dates Aug 20–27, 2026.
Bearish
5
Neutral
6
Bullish
3
Bearish
15
Neutral
6
Bullish
25
Bearish
10
Neutral
0
Bullish
22
